Biocryst Pharmaceuticals Inc (BCRX)

Investing Cash Flow

-$110.15M

Quarterly · Period ending: · USD

BCRX logo

BCRX Investing Cash Flow

Latest reported-$110.15M
BCRX Quarterly Cash from Investing (-$7.80M → -$110.15M)
High-resolution chart · PNG

BCRX investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-110,148,000
-268,648,000
-83,488,000
13,572,000
29,127,000
27,095,000
17,797,000
8,489,000
-2,449,000
28,756,000
-28,473,000
23,119,000
-19,035,000
-107,109,000
77,215,000
-69,543,000
-97,438,000
-38,472,000
-11,120,000
7,747,000
4,504,000
14,673,000
21,414,000
-34,062,000
-4,932,000
10,724,000
16,261,000
23,514,000
22,278,000
15,881,000
-3,167,000
-9,525,000
1,533,000
15,927,000
-57,548,000
4,198,000
-25,913,000
12,881,000
-9,761,000
21,949,000
8,444,000
2,707,000
-2,987,000
-18,141,000
7,072,000
-3,948,000
-53,088,000
4,865,000
9,266,000
-1,023,000
-2,262,000
-5,809,000
2,532,000
2,072,000
3,646,000
11,675,000
-1,977,000
11,540,000
-2,692,000
16,341,000
-10,090,000
7,759,000
8,123,068
6,260,000
2,247,000
-16,409,000
-33,026,416
8,040,000
9,159,000
2,933,000
10,901,919
-3,435,000
3,181,000
746,000
3,035,644
-23,878,000
-2,083,000
7,892,000
11,457,792
-4,437,000
-4,779,000
-14,731,000
-5,376,058
4,818,000
-6,894,000
-4,062,000
3,916,033
434,000
-94,000
-7,093,000
2,957,000
-129,000
5,127,000
458,000
2,537,437
2,047,000
905,000
5,711,000
2,713,058
3,475,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.